|
|
|
Thursday, 06 April 2006 |
- Treatment should be initiated as soon as possible after diagnosis
- Single-dose regimens have the advantage of improved compliance and of DOT
- To improve compliance, the medication should be provided in the clinic or health-care provider's office.
Recommended Regimens
Azithromycin 1 g orally in a single dose, OR Doxycycline 100 mg orally twice a day for 7 days.
Alternative Regimens
Erythromycin base 500 mg orally four times a day for 7 days, OR Erythromycin ethylsuccinate 800 mg orally four times a day for 7 days, OR Ofloxacin 300 mg twice a day for 7 days, OR Levofloxacin 500 mg once daily for 7 days.
Follow-Up for Patients Who Have Urethritis
- Patients should be instructed to return for evaluation if symptoms persist or recur after completion of therapy
- Symptoms alone, without documentation of signs or laboratory evidence of urethral inflammation, are not a sufficient basis for re-treatment
- Patients should be instructed to abstain from sexual intercourse until 7 days after therapy is initiated
Recurrent and Persistent Urethritis
- Objective signs of urethritis should be present before initiation of antimicrobial therapy
- Effective regimens have not been identified for treating patients who do not have objective signs of urethritis but who have persistent symptoms after treatment
- Patients who have persistent or recurrent urethritis should be re-treated with the initial regimen if they did not comply with the treatment regimen or if they were reexposed to an untreated sex partner. Otherwise, a culture of an intra-urethral swab specimen and a first-void urine specimen for T. vaginalis should be performed
- Some cases of recurrent urethritis following doxycycline treatment may be caused by tetracycline-resistant U. urealyticum
- Urologic examinations usually do not reveal a specific etiology. If the patient was compliant with the initial regimen and re-exposure can be excluded, the following regimen is recommended.
Recommended Regimens Metronidazole 2 g orally in a single dose PLUS Erythromycin base 500 mg orally four times a day for 7 days OR Erythromycin ethylsuccinate 800 mg orally four times a day for 7 days.
References
Sexually Transmitted Diseases Treatment Guidelines 2002 MMWR Morbidity and Mortality Weekly Report Recommendation and Reports May 10, 2002/Vol. 51/No.RR-6Please log-in or register in order to submit comments. Powered by AkoComment! |